Provocative @JAMA_current piece on #AMCs by @ClayDellMed bit.ly/2ZwU2d5 For new school like Dell, focusing on new models makes sense. For thriving AMC like @UCSF, hard to disrupt (w/o harming missions) before incentives change. I see my #1 job as balancing these tensions
By the way, this isn't argument that AMCs should just accept the status quo, not work their tails off on innovation/value/pop health, or fight the tendency to prioritize clinical profits over education/research. All are critical and @UCSF we're trying to do our part.
And I'm grateful to Dell and other new schools for blazing paths that are harder for "legacy" orgs. It's what start-ups should do, and the history of start-ups is that they sometimes end up eating the lunch of the old "battleships" that couldn't or wouldn't change. We'll see...
